Immunogenicity and protective efficacy of an intranasal neuraminidase-based influenza vaccine with bacterial cell membrane-derived adjuvants.

The rNA-N1-MPP group showed a trend toward increased percentages of eosinophils, basophils, and mast cells compared with PBS or adjuvanted groups.

also in 53,322 other papers

BDX301 boosted these populations to nearly the same levels achieved with BDX100, although the difference did not reach statistical significance.

also in 111,027 other papers